Latest & greatest articles for type 2 diabetes

The Trip Database is a leading resource to help health professionals find trustworthy answers to their clinical questions. Users can access the latest research evidence and guidance to answer their clinical questions. We have a large collection of systematic reviews, clinical guidelines, regulatory guidance, clinical trials and many other forms of evidence. If you wanted the latest trusted evidence on type 2 diabetes or other clinical topics then use Trip today.

This page lists the very latest high quality evidence on type 2 diabetes and also the most popular articles. Popularity measured by the number of times the articles have been clicked on by fellow users in the last twelve months.

What is Trip?

Trip is a clinical search engine designed to allow users to quickly and easily find and use high-quality research evidence to support their practice and/or care.

Trip has been online since 1997 and in that time has developed into the internet’s premier source of evidence-based content. Our motto is ‘Find evidence fast’ and this is something we aim to deliver for every single search.

As well as research evidence we also allow clinicians to search across other content types including images, videos, patient information leaflets, educational courses and news.

For further information on Trip click on any of the questions/sections on the left-hand side of this page. But if you still have questions please contact us via jon.brassey@tripdatabase.com

Top results for type 2 diabetes

181. Systematic review and meta-analysis of vitamin D supplementation in the treatment of type 2 diabetic microangiopathy Full Text available with Trip Pro

Systematic review and meta-analysis of vitamin D supplementation in the treatment of type 2 diabetic microangiopathy Inplasy Protocol 288 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

182. Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. Full Text available with Trip Pro

Progression to type 2 diabetes in women with a known history of gestational diabetes: systematic review and meta-analysis. To estimate and compare progression rates to type 2 diabetes mellitus (T2DM) in women with gestational diabetes mellitus (GDM) and healthy controls.Systematic review and meta-analysis.Medline and Embase between January 2000 and December 2019, studies published in English and conducted on humans.Observational studies investigating progression to T2DM. Inclusion criteria were (...) postpartum follow-up for at least 12 months, incident physician based diagnosis of diabetes, T2DM reported as a separate outcome rather than combined with impaired fasting glucose or impaired glucose tolerance, and studies with both a group of patients with GDM and a control group.This meta-analysis of 20 studies assessed a total of 1 332 373 individuals (67 956 women with GDM and 1 264 417 controls). Data were pooled by random effects meta-analysis models, and heterogeneity was assessed by use of the I2

2020 BMJ

183. Comparative efficacy of bariatric surgery for type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis Full Text available with Trip Pro

Comparative efficacy of bariatric surgery for type 2 diabetes mellitus: A protocol for systematic review and network meta-analysis Inplasy Protocol 286 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

184. Effect of Sancai Powder on Glacemic Variability of Type 1 Diabetes in China: a protocol for systematic review and meta-analysis Full Text available with Trip Pro

Effect of Sancai Powder on Glacemic Variability of Type 1 Diabetes in China: a protocol for systematic review and meta-analysis Inplasy Protocol 285 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review and Meta-analysis Protocols

185. Weight maintenance interventions for people with type 2 diabetes mellitus: A systematic review protocol Full Text available with Trip Pro

Weight maintenance interventions for people with type 2 diabetes mellitus: A systematic review protocol Weight maintenance interventions for people with type 2 diabetes mellitus: A systematic review protocol | Research Square Browse Tools & Services Your Cart See the published version of this article at . This is a preprint, a preliminary version of a manuscript that has not completed peer review at a journal. Research Square does not conduct peer review prior to posting preprints. The posting (...) of a preprint on this server should not be interpreted as an endorsement of its validity or suitability for dissemination as established information or for guiding clinical practice. Protocol Weight maintenance interventions for people with type 2 diabetes mellitus: A systematic review protocol Sarah Sauchelli, Julia Bradley, Jennifer Cox, Clare England, Rachel Perry Sarah Sauchelli NIHR Bristol Biomedical Research Centre (Nutrition Theme) Corresponding Author ORCiD: https://orcid.org/0000-0003-3620-7671

2020 Research Square

186. Care of the Well Child-Newly Diagnosed with Type 1 Diabetes

published ahead of print September 6, 2012, doi:10.2337/dc12-0720 15. Canadian Agency for Drugs and Technologies in Health. Systematic review of use of blood glucose test strips for the management of diabetes mellitus. [June 2010]. Available from.www.cadth.ca/products/cadth-overviews/vol-1.../vol-1-issue-1-01 16. NICE (2015) Diabetes (type 1 and type 2) in children and young people. NICE guideline NG18 www.nice.org.uk/guidance/ng18 Version 4, Dec 2019 Review 2022 Authors: J Chizo Agwu, SM Ng, A Timmis (...) care in children at diagnosis of tyoe 1 diabetes mellitus. Cochrane Database of systematic reviews2007, issue 2. Art No: CD004099. DOI: 10.1002/14651858.CD004009.pub 2 19. Home based care improved glycaemic control and was cost effective in children with type 1 diabetes. Dougherty G, Schriffin A, White D, et al. Pediatrics 1999 Jan; 103: 122-8. 20. The delivery of ambulatory diabetes care to children and adolescents with diabetes. Pihoker C, Forsander G, Wolfsdorf J, Klingensmith GJ. Pediatric

2020 British Society for Paediatric Endocrinology and Diabetes

187. Management of Hypoglycaemia in Children and Young People with Type 1 Diabetes

and caregivers, especially when there is a high risk of severe hypoglycaemia. Education on administration of glucagon is essential Blood glucose monitoring should be performed prior to exercise, and extra carbohydrates should be consumed based on the blood glucose level and the expected intensity and duration of the exercise REFERENCE 1. NICE (2015) Diabetes (type 1 and type 2) in children and young people. NICE guideline NG18 www.nice.org.uk/guidance/ng18 2. ISPAD Clinical Practice Consensus Guidelines 2014 (...) Management of Hypoglycaemia in Children and Young People with Type 1 Diabetes ssociation of Children’s Diabetes Clinicians Clinicians Version 4, May 2018 Review 2021 Authors: SM Ng, E Williams, F Ackland, C Burren, J Edge, E Hind, A McAulay, Bill Lamb 1 SETTING Children and young people with diabetes mellitus PATIENTS Children and young people with diabetes mellitus Guidance • Definition of hypoglycaemia in children with diabetes is a blood glucose 4.0mmol/L, Retest 20-30 minutes later

2020 British Society for Paediatric Endocrinology and Diabetes

188. Dulaglutide (Trulicity) and type 2 diabetes. No reduction in all-cause mortality or cardiovascular mortality

Dulaglutide (Trulicity) and type 2 diabetes. No reduction in all-cause mortality or cardiovascular mortality Prescrire IN ENGLISH - Spotlight '' Dulaglutide (Trulicity) and type 2 diabetes. No reduction in all-cause mortality or cardiovascular mortality'', 1 May 2020 {1} {1} {1} | | > > > Dulaglutide (Trulicity) and type 2 diabetes. No reduction in all-cause mortality or cardiovascular mortality Spotlight Every month, the subjects in Prescrire’s Spotlight. 100 most recent :  |    (...) |   |   |   |   |   |   |   |  Spotlight In the May issue of Prescrire International: Dulaglutide (Trulicity°) and type 2 diabetes. No reduction in all-cause mortality or cardiovascular mortality FREE DOWNLOAD In patients with type 2 diabetes who had a modest elevation of HbA1c, a recent trial suggested that addition of dulaglutide to hypoglycaemic therapy slightly reduced the risk of stroke, but did not reduce either all-cause mortality

2020 Prescrire

189. Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial Full Text available with Trip Pro

Differential glycaemic control with basal insulin glargine 300 U/mL versus degludec 100 U/mL according to kidney function in type 2 diabetes: A subanalysis from the BRIGHT trial Differential Glycaemic Control With Basal Insulin Glargine 300 U/mL Versus Degludec 100 U/mL According to Kidney Function in Type 2 Diabetes: A Subanalysis From the BRIGHT Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search (...) : Save Cancel Create a file for external citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation Diabetes Obes Metab Actions . 2020 Apr 3. doi: 10.1111/dom.14043. Online ahead of print. Differential Glycaemic Control With Basal Insulin Glargine 300 U/mL Versus Degludec 100 U/mL According to Kidney Function in Type 2 Diabetes: A Subanalysis From the BRIGHT Trial , , , , , , , , , Affiliations Expand Affiliations 1 Diabetes Centre, Institute for Clinical

2020 EvidenceUpdates

190. Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial Full Text available with Trip Pro

Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2 Diabetes Inadequately Controlled on Oral Antidiabetic Drugs: The LixiLan JP-O1 Randomized Clinical Trial (...) : ( ) Frequency: Which day? Which day? Report format: Send at most: Send even when there aren't any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation Diabetes Care Actions . 2020 Apr 15;dc192452. doi: 10.2337/dc19-2452. Online ahead of print. Efficacy and Safety of 1:1 Fixed-Ratio Combination of Insulin Glargine and Lixisenatide Versus Lixisenatide in Japanese Patients With Type 2

2020 EvidenceUpdates

191. Metabolic surgery for the treatment of type 2 diabetes: A network meta-analysis of randomized controlled trials Full Text available with Trip Pro

Metabolic surgery for the treatment of type 2 diabetes: A network meta-analysis of randomized controlled trials Metabolic Surgery for the Treatment of Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials - PubMed This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features! Clipboard, Search History, and several other advanced features are temporarily unavailable. National Institutes of Health National Library of Medicine (...) Diabetes Obes Metab Actions . 2020 Apr 3. doi: 10.1111/dom.14045. Online ahead of print. Metabolic Surgery for the Treatment of Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials , , , Affiliations Expand Affiliations 1 Diabetology, Careggi Hospital, Florence, Italy. 2 University of Florence, Florence, Italy. PMID: 32243058 DOI: Item in Clipboard Metabolic Surgery for the Treatment of Type 2 Diabetes: A Network Meta-Analysis of Randomized Controlled Trials Barbara Cresci et al

2020 EvidenceUpdates

192. Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial Full Text available with Trip Pro

, , , , , , Affiliations Expand Affiliations 1 Department of Experimental and Clinical Biomedical Sciences, University of Florence, Florence, Italy. 2 Diabetes Unit, Careggi Teaching Hospital, Florence, Italy. PMID: 32166907 DOI: Item in Clipboard Combined Continuous Glucose Monitoring and Subcutaneous Insulin Infusion Versus Self-Monitoring of Blood Glucose With Optimized Multiple Injections in People With Type 1 Diabetes: A Randomized Crossover Trial Ilaria Dicembrini et al. Diabetes Obes Metab . 2020 . Show details (...) Combined continuous glucose monitoring and subcutaneous insulin infusion versus self-monitoring of blood glucose with optimized multiple injections in people with type 1 diabetes: A randomized crossover trial Combined Continuous Glucose Monitoring and Subcutaneous Insulin Infusion Versus Self-Monitoring of Blood Glucose With Optimized Multiple Injections in People With Type 1 Diabetes: A Randomized Crossover Trial - PubMed This site needs JavaScript to work properly. Please enable it to take

2020 EvidenceUpdates

193. Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial

Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial - PubMed This site needs JavaScript to work properly. Please enable it to take advantage (...) any new results Optional text in email: Save Cancel Create a file for external citation management software Create file Cancel Actions Cite Share Permalink Copy Page navigation Circulation Actions . 2020 Apr 21;141(16):1295-1306. doi: 10.1161/CIRCULATIONAHA.119.044865. Epub 2020 Mar 5. Association of Intensive Lifestyle Intervention, Fitness, and Body Mass Index With Risk of Heart Failure in Overweight or Obese Adults With Type 2 Diabetes Mellitus: An Analysis From the Look AHEAD Trial

2020 EvidenceUpdates

194. A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9) Full Text available with Trip Pro

A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9) A Randomized Trial Evaluating the Efficacy and Safety of Fast-Acting Insulin Aspart Compared With Insulin Aspart, Both in Combination With Insulin Degludec With or Without Metformin, in Adults With Type 2 Diabetes (Onset 9) - PubMed This site needs JavaScript to work (...) , in Adults With Type 2 Diabetes (Onset 9) , , , , , , , , , , Affiliations Expand Affiliations 1 Mountain Diabetes and Endocrine Centre, Asheville, NC mountaindiabetes@msn.com. 2 Novo Nordisk A/S, Søborg, Denmark. 3 Department of Internal Medicine, Seoul National University College of Medicine and Seoul National University Bundang Hospital, Seongnam, South Korea. 4 Novo Nordisk A/S, Aalborg, Denmark. 5 Santojanni Hospital and CENUDIAB, Ciudad Autonoma de Buenos Aires, Buenos Aires, Argentina. 6 Institute

2020 EvidenceUpdates

195. Association between PPARγ rs1801282 polymorphism with diabetic nephropathy and type-2 diabetes mellitus susceptibility in south India and a meta-analysis Full Text available with Trip Pro

Association between PPARγ rs1801282 polymorphism with diabetic nephropathy and type-2 diabetes mellitus susceptibility in south India and a meta-analysis Redirecting

2020 Nefrología

196. Association between PPARγ rs1801282 polymorphism with diabetic nephropathy and type-2 diabetes mellitus susceptibility in south India and a meta-analysis Full Text available with Trip Pro

Association between PPARγ rs1801282 polymorphism with diabetic nephropathy and type-2 diabetes mellitus susceptibility in south India and a meta-analysis Redirecting

2020 Nefrología (English Edition)

197. Effects of different dosages of Sodium-Glucose Transporter 2 Inhibitors on lipid levels in patients with type 2 diabetes mellitus: a systematic review and meta-analysis Full Text available with Trip Pro

Effects of different dosages of Sodium-Glucose Transporter 2 Inhibitors on lipid levels in patients with type 2 diabetes mellitus: a systematic review and meta-analysis Inplasy Protocol 223 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review Protocols

198. Systematic review with meta-analysis of the epidemiological evidence relating smoking to type 2 diabetes Full Text available with Trip Pro

Systematic review with meta-analysis of the epidemiological evidence relating smoking to type 2 diabetes Systematic review with meta-analysis of the epidemiological evidence relating smoking to type 2 diabetes BPG is committed to discovery and dissemination of knowledge This Article Full Article (HTML) (62) Full Article (PDF) (19) Academic Content and Language Evaluation of This Article CrossCheck and Google Search of This Article Academic Rules and Norms of This Article Supplementary Materials (...) of This Article Citation of this article Lee PN, Coombs KJ. Systematic review with meta-analysis of the epidemiological evidence relating smoking to type 2 diabetes. World J Meta-Anal 2020; 8(2): 119-152 Corresponding Author of This Article Peter N Lee, MA, Director, Senior Statistician, Director and Consultant Medical Statistician, Department of Statistics, P.N. Lee Statistics and Computing Ltd., 17 Cedar Road, Sutton SM2 5DA, Surrey, United Kingdom. peterLee@pnlee.co.uk Checklist of Responsibilities

2020 World journal of meta-analysis

199. Comparative efficacy of GLP-1 RAs and SGLT2is for prevention of major adverse cardiovascular events in type 2 diabetes: a network meta-analysis Full Text available with Trip Pro

Comparative efficacy of GLP-1 RAs and SGLT2is for prevention of major adverse cardiovascular events in type 2 diabetes: a network meta-analysis Inplasy Protocol 199 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review Protocols

200. Serum vitamin D levels and type 2 diabetic erectile dysfunction: a systematic review and meta-analysis Full Text available with Trip Pro

Serum vitamin D levels and type 2 diabetic erectile dysfunction: a systematic review and meta-analysis Inplasy Protocol 186 - INPLASY.COM International Platform of Registered Systematic Review and Meta-analysis Protocols Main Menu Share this: Copyright © 2021 INPLASY.COM Powered by INPLASY.COM

2020 INPLASY - International Platform of Registered Systematic Review Protocols